Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 17, 2007

Nexgen Acquires Colorado-Based Manufacturing Facility

  • Nexgen Pharma gained certain assets of The Chemins Company, including 250,000 sq. ft. of manufacturing, laboratory, and warehouse/distribution space.

    “We have not only expanded our capacities but also our dosage form capabilities,” states Gary Korngold, executive vp. “The result will be increased offerings to the industry and the ability to meet the increased demands for our products and services.”

    Currently, Nexgen has five facilities located in Irvine, CA, Tempe and Phoenix, AZ, Colorado Springs, CO, and Columbia, MO, according to the company. This reportedly totals over 400,000 sq. ft. of manufacturing, laboratory, and warehouse/distribution space.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »